Health Catalyst (Health Catalyst) Long-Term Capital Lease Obligation : $17.1 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Health Catalyst Long-Term Capital Lease Obligation?

Health Catalyst's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $17.1 Mil.

Health Catalyst's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 ($18.2 Mil) to Dec. 2023 ($17.7 Mil) and declined from Dec. 2023 ($17.7 Mil) to Mar. 2024 ($17.1 Mil).

Health Catalyst's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($20.2 Mil) to Dec. 2022 ($18.0 Mil) and declined from Dec. 2022 ($18.0 Mil) to Dec. 2023 ($17.7 Mil).

Health Catalyst Long-Term Capital Lease Obligation Historical Data

The historical data trend for Health Catalyst's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health Catalyst Long-Term Capital Lease Obligation Chart

Health Catalyst Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.65

23.67

20.24

18.02

17.68

Health Catalyst Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															17.45	18.78	18.23	17.68	17.11

Health Catalyst (NAS:HCAT) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Health Catalyst Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Health Catalyst's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Health Catalyst (Health Catalyst) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Health Catalyst Inc (NAS:HCAT) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

2YP:Germany

Address

10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095

Website

https://www.healthcatalyst.com

Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Executives

Linda Llewelyn	officer: Chief People Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Jason Alger	officer: Chief Accounting Officer	C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Benjamin Landry	officer: General Counsel	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Matthew Kolb	director	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Bryan Truman Hunt	officer: Chief Financial Officer	C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Daniel D. Burton	director, officer: Chief Executive Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anne Marie Bickmore	officer: COO and Chief Product Officer	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Kevin Lee Freeman	officer: Chief Growth Officer	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Daniel H. Orenstein	officer: General Counsel	311 ARSENAL STREET, WATERTOWN MA 02472
Duncan Gallagher	director	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Paul Horstmeier	officer: Chief Operating Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Bryan Richard Hinton	officer: Chief Technology Officer	C/O HEALTH CATALYST, 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN UT 84095
Nelli James Patrick Jr.	officer: Chief Financial Officer	C/O HEALTH CATALYST, INC., 3165 E.MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anita Pramoda	director	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Timothy G. Ferris	director	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE, #400, SALT LAKE CITY UT 84121